These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

94 related articles for article (PubMed ID: 10603607)

  • 1. [Five-ring analogs of nifedipine. 3. Synthesis and reactions of 1,4-dihydropyridines with 4-(4-nitro-5-imidazolyl)-substituents].
    Görlitzer K; Klanck S
    Pharmazie; 1999 Nov; 54(11):814-9. PubMed ID: 10603607
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Synthesis and calcium channel antagonist activity of nifedipine analogues containing 1,2-dihydropyridyl in place of the 1,4-dihydropyridyl moiety.
    Soboleski DA; Li-Kwong-Ken MC; Wynn H; Triggle CR; Wolowyk MW; Knaus EE
    Drug Des Deliv; 1988 Feb; 2(3):177-89. PubMed ID: 2855573
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Design, synthesis, and calcium channel antagonist activity of new 1,4-dihydropyridines containing 4-(5)-chloro-2-ethyl-5-(4)-imidazolyl substituent.
    Davood A; Mansouri N; Rerza Dehpour A; Shafaroudi H; Alipour E; Shafiee A
    Arch Pharm (Weinheim); 2006 Jun; 339(6):299-304. PubMed ID: 16649160
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Design and synthesis of new 1,4-dihydropyridines containing 4(5)-chloro-5(4)-imidazolyl substituent as a novel calcium channel blocker.
    Iman M; Davood A; Nematollahi AR; Dehpoor AR; Shafiee A
    Arch Pharm Res; 2011 Sep; 34(9):1417-26. PubMed ID: 21975802
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Potential antiallergics. 3. Synthesis and transformations of 1,4-dihydro-4-oxo-(1)benzothieno(3,2-b)pyridine-2-carboxylic acid esters].
    Görlitzer K; Kramer C
    Pharmazie; 2000 Sep; 55(9):645-50. PubMed ID: 11031766
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Benzo[c][2,7]naphthyridines from 2,6-dinor-nifedipine and its dimethyl 2,5-dicarboxylate isomer].
    Görlitzer K; Bode M; Frohberg P; Drutkowski G
    Pharmazie; 2004 Jan; 59(1):15-20. PubMed ID: 14964415
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Synthesis, study of 3D structures, and pharmacological activities of lipophilic nitroimidazolyl-1,4-dihydropyridines as calcium channel antagonist.
    Miri R; Javidnia K; Sarkarzadeh H; Hemmateenejad B
    Bioorg Med Chem; 2006 Jul; 14(14):4842-9. PubMed ID: 16603367
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [The reaction mechnism for formation of a 9-hydroxy-beta-carbolin-4-carboxylic acid from the nifedipine analogue biscyanoethyl ester].
    Görlitzer K; Baltrusch HJ
    Pharmazie; 2000 Oct; 55(10):747-50. PubMed ID: 11082835
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Potential antiallergic agents--synthesis and reactions of 1,4-dihydro-4-oxo-(1)benzofuro(3,2-b)pyridin-2-carboxylic acid esters].
    Görlitzer K; Kramer C
    Pharmazie; 2000 Aug; 55(8):587-94. PubMed ID: 10989836
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Facile and efficient aromatization of 1,4-dihydropyridines with M(NO3)2.XH2O, TNCB, TBAP and HMTAI and preparation of deuterium labeled dehydronifedipine from nifedipine-d3.
    Shaikh AC; Chen C
    Bioorg Med Chem Lett; 2010 Jun; 20(12):3664-8. PubMed ID: 20472427
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Bisbenzothieno[3,2-b: 2',3'-e]pyridines].
    Görlitzer K; Meyer H
    Pharmazie; 2004 Sep; 59(9):673-5. PubMed ID: 15497746
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Synthesis and calcium channel antagonist activity of nifedipine analogues containing 4(5)-chloro-2-methyl-5(4)-imidazolyl substituent.
    Davood A; Khodarahmi G; Alipour E; Dehpour K; Amini M; Shafiee A
    Boll Chim Farm; 2001; 140(6):381-6. PubMed ID: 11822226
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Reactions of 4,5-dihydro-4-oxo-1H-pyrido(3,2-b)indol-2-carboxylic acid ester].
    Görlitzer K; Kramer C
    Pharmazie; 2000 Apr; 55(4):273-81. PubMed ID: 10798240
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Synthesis of some 4-[3' or 4'-(4H- 4-oxo-1-benzopyran-2-yl)phenyl]-1,4-dihydropyridine derivatives as potential calcium channel antagonists.
    Tunçbilek M; Ertan R
    Pharmazie; 1999 Apr; 54(4):255-9. PubMed ID: 10234737
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Synthesis and evaluation of pharmacological activities of 3, 5-dialkyl 1, 4-dihydro-2,6-dimethyl-4-nitroimidazole-3, 5-pyridine dicarboxylates.
    Miri R; Javidnia K; Kebriaie-Zadeh A; Niknahad H; Shaygani N; Semnanian S; Shafiee A
    Arch Pharm (Weinheim); 2003 Sep; 336(9):422-8. PubMed ID: 14528490
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Photochemical stabilities of some dihydropyridine calcium-channel blockers in powdered pharmaceutical tablets.
    Kawabe Y; Nakamura H; Hino E; Suzuki S
    J Pharm Biomed Anal; 2008 Jul; 47(3):618-24. PubMed ID: 18339506
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Strategies for the synthesis of nifedipine analog esters of l-ascorbic acid].
    Görlitzer K; Baltrusch HJ
    Pharmazie; 2001 Mar; 56(3):208-13. PubMed ID: 11265584
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Oxidative aromatization of Hantzsch 1,4-dihydropyridines in the presence of mixed-addenda vanadomolybdophosphate heteropolyacid, H6PMo9V3O40.
    Heravi MM; Derikvand F; Hassan-Pour S; Bakhtiari K; Bamoharram FF; Oskooie HA
    Bioorg Med Chem Lett; 2007 Jun; 17(12):3305-9. PubMed ID: 17452103
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Studies on nilvadipine. I. Synthesis and structure-activity relationships of 1,4-dihydropyridines containing novel substituents at the 2-position.
    Satoh Y; Ichihashi M; Okumura K
    Chem Pharm Bull (Tokyo); 1991 Dec; 39(12):3189-201. PubMed ID: 1814611
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Syntheses and calcium channel antagonist activity of nifedipine analogues with methylsulfonylimidazolyl substituent.
    Shafiee A; Dehpour AR; Hadizadeh F; Azimi M
    Pharm Acta Helv; 1998 Jul; 73(2):75-9. PubMed ID: 9700935
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.